

Oncology
Mark Murakami, M.D.
Director, Mantle Cell Lymphoma Center; Director, Follicular Lymphoma Center
Dr. Mark Murakami is a physician at Dana-Farber Cancer Institute specializing in Clinical genomics, Experimental therapeutics, Minimal residual disease, Precision medicine, Predictive Biomarkers, serving as Director, Mantle Cell Lymphoma Center; Director, Follicular Lymphoma Center.
Is Dr. Murakami right for you?
We'll build a personalized evaluation of Dr. Murakami for your case, side-by-side against the top alternatives in their subspecialty.
- In-depth evaluation of Dr. Murakami for your specific case
- Side-by-side comparison vs. the top alternatives
Fully credited toward membership if you join within 30 days
$25
Credentials
Board Certifications
- Hematology
- Internal Medicine
- Medical Oncology
Education & Training
- Washington University School of Medicine (MD)
- Massachusetts General Hospital (Residency)
- Dana-Farber Cancer Institute (Fellowship)
- Dana-Farber/Partners CancerCare (Fellowship)
Years in Practice
17+ years
Peer Recognition
- Healthgrades — Healthgrades Honor Roll
Clinical Focus
Subspecialties
Conditions & Treatments
Insurance(s) Accepted
Please verify your coverage with the provider — plan participation can change.
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Dana-Farber/Brigham and Women's Cancer Center
Conditions Dr. Murakami treats
Insurance accepted
Frequently asked
Does Dr. Murakami accept Aetna insurance?
Where does Dr. Murakami practice?
What does Dr. Murakami specialize in?
How long has Dr. Murakami been practicing?
What is Dr. Murakami's medical training?
Specialists similar to Dr. Murakami
More medical oncology specialists in Massachusetts











